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Abstract 
Objectives 
High Bone Mass (HBM) is associated with (a) radiographic knee osteoarthritis (OA), partly mediated 
by increased BMI, and (b) pelvic enthesophytes and hip osteophytes, suggestive of a bone-forming 
phenotype. We aimed to establish whether HBM is associated with radiographic features of OA in 
non weight-bearing (hand) joints, and whether such OA demonstrates a bone-forming phenotype.  
Methods 
HBM cases (BMD Z-scores ≥+3.2) were compared with family controls. A blinded assessor graded all 
PA hand radiographs for: osteophytes (0-3), joint space narrowing (JSN)(0-3), subchondral sclerosis 
(0-1), at the index Distal Interphalangeal Joint (DIPJ) and 1st Carpometacarpal Joint (CMCJ), using an 
established atlas. Analyses used a random effects logistic regression model, adjusting a priori for age 
and gender. Mediating roles of BMI and bone turnover markers (BTMs) were explored by further 
adjustment. 
Results  
314 HBM cases (mean age 61.1years, 74% female) and 183 controls (54.3years, 46% female) were 
included. Osteophytes (grade≥1) were more common in HBM (DIPJ: 67% vs. 45%, CMCJ: 69% vs. 
50%), with adjusted OR [95% CI] 1.82 [1.11, 2.97], p=0.017 and 1.89 [1.19, 3.01], p=0.007 
respectively; no differences were seen in JSN. Further adjustment for BMI failed to attenuate ORs for 
osteophytes in HBM cases vs. controls; DIPJ 1.72 [1.05, 2.83], p=0.032, CMCJ 1.76 [1.00, 3.06], 
p=0.049. Adjustment for BTMs (concentrations lower amongst HBM cases) did not attenuate ORs. 
Conclusions 
HBM is positively associated with OA in non weight-bearing joints, independent of BMI. HBM-
associated OA is characterised by osteophytes, consistent with a bone-forming phenotype, rather 
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than JSN reflecting cartilage loss. Systemic factors (e.g. genetic architecture) which govern HBM may 
also increase bone-forming OA risk. 
 
Keywords 
Osteoarthritis; Osteophyte; Bone; Hand; Epidemiology; X-ray  
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1. Introduction 
Epidemiological studies have consistently demonstrated an association between higher bone 
mineral density (BMD) and both prevalent (1-4) and incident (5-7) radiographic osteoarthritis (OA) of 
large joints. To gain insights into mechanisms underlying this BMD-OA relationship, we recently 
studied the prevalence and phenotype of OA in a unique High Bone Mass (HBM) population. We 
have found that HBM individuals have a higher prevalence of self-reported joint replacement and 
use of non-steroidal anti-inflammatory drugs (NSAIDs) compared with family controls (8). An 
increased prevalence of radiographic hip OA was also observed in HBM individuals, particularly with 
respect to bony features such as osteophytosis and subchondral sclerosis, whereas little evidence  
was seen for features reflecting cartilage loss such as joint space narrowing (JSN)(9). Further 
characterisation of knee OA revealed a similar, osteophyte-predominant, radiographic OA 
phenotype (10). Additional evidence of a ‘bone-forming’ tendency is supported by a greater 
prevalence and severity of radiographic pelvic enthesophytes (bony spurs at tendon/ligament 
insertions) seen in HBM individuals, compared with family controls (11). 
 
Interestingly, HBM individuals also tend to have a greater body mass index (BMI) (12), and women 
with HBM have elevated fat mass on total body DXA with a particular tendency towards central 
adiposity (13). Whilst genetic sequencing is ongoing, HBM cases are thought to have a genetic 
predisposition to their raised BMD suggesting a causal pathway whereby raised BMD leads to 
increased fat mass (13, 14). Mouse models have suggested bone turnover directly influences insulin 
sensitivity and adiposity via a relay involving osteocalcin (an osteoblast-specific protein) and 
adiponectin (an adipokine produced by white adipose tissue). Reduced bone turnover, resulting in 
decreased osteocalcin, has been associated with lower adiponectin, impaired insulin sensitivity, and 
increased fat deposition due to reduced energy expenditure (6). Obesity is an established risk factor 
for OA, particularly in large weight-bearing joints; increased mechanical load is considered 
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deleterious to joints (12, 15). However, although greater BMI contributed in part to the association 
we observed between HBM and knee OA, the association persisted after BMI adjustment (10), and 
the relationship between HBM and hip OA appeared independent of BMI (9). 
 
The observation that obesity is also associated with OA in non weight-bearing joints, i.e. the hand 
(16), suggests adiposity may also modify OA risk via metabolic pathways, e.g. through increased 
circulating adipokines or chronic inflammation (17, 18).  The relative importance of these two 
pathways (mechanical vs. metabolic) in mediating the BMI-OA association remains to be 
determined. We aimed to establish whether HBM is associated with OA in non weight-bearing joints, 
and if so whether such OA also demonstrates a bone-forming phenotype and whether increased BMI 
contributes to any identified association. We hypothesized that, in line with our previous findings 
and evidence from general population studies (11), HBM would be associated with a ‘bone-forming’ 
phenotype of OA in non weight-bearing joints potentially reflecting underlying systemic factors.  
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2. Methods 
2.1. Participant recruitment 
HBM cases were recruited as part of the UK-based HBM study, a multi-centre observational study of 
adults with unexplained HBM; full details of DXA database screening and recruitment have 
previously been reported (12). Potential index cases were initially identified by screening 13 National 
Health Service (NHS) DXA databases (335,115 DXA scans in total) for T and/or Z-scores ≥+4 at any 
site within the lumbar spine or hip.  Previous case studies of HBM used Z-score thresholds to define 
HBM (19); however, as Hologic DXA scanner databases store T- but not Z-scores, our search was of T- 
and/or Z-score≥+4. All DXA images were inspected by trained clinicians to exclude scans with 
artefactual elevation of DXA BMD, resulting in 49.4% of scans being excluded due to degenerative 
disease/osteoarthritis/scoliosis, and a further 15.5% for other reasons including surgical/malignant/ 
Pagetic artefacts etc. To reduce contamination of our remaining DXA scans by more moderate OA, 
we aimed to refine our case definition based upon restriction to specific lumbar verterba(e). At our 
largest centre 463 antero-posterior DXA scans with T/Z-score ≥+4 were graded for OA severity by 
lateral Kellgren & Lawrence scores, and examined in relation to BMD at lumbar vertebral levels (20, 
21). Total L1-L4 Z-score was strongly associated with increasing KL score (β coefficient 1.01 *0.54, 
1.48], p<0.001) (21); in contrast to other lumbar vertebrae, L1 Z-score was not associated with the 
presence of OA (0.04 [-0.53, 0.60], p=0.89) (21), reflecting the recognized pattern of progressive OA 
changes seen in descending sequential lumbar vertebrae (22, 23). Nor did total hip Z-score reflect 
lumbar spine OA (21). As a generalized HBM trait is expected to affect both spine and hip BMD, 
though not necessary to the same extent, we refined our HBM index case definition as having either 
a) L1 Z-score ≥+3.2 plus total hip Z-score ≥+1.2 or b) total hip Z-score ≥+3.2 plus L1 Z-score ≥+1.2.  A 
+3.2 threshold was consistent with the only published precedent for identifying HBM using DXA (24) 
and most appropriately differentiated generalized HBM from artefact.. Z rather than T-score limited 
age bias. 
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Further HBM cases were identified through DXA assessment of the relatives and spouses of index 
cases. In first-degree relatives, HBM was defined as a summed L1 Z-score plus total hip Z-score ≥+3.2 
(12). BMD was standardized using established formulae (25, 26). 41% of relatives screened were 
affected and combined with HBM index cases, with remaining unaffected first-degree 
relatives/spouses forming a family control group. Standardised clinical assessments, performed by a 
doctor or research nurse, including a structured interview, clinical examination and weight and 
height measurement, were identical in both HBM cases and controls. Concurrently, PA dominant 
hand X-rays were performed in all participants according to local protocols at each centre.  Those 
reporting joint pain/ aching/ stiffness (27) for months/ years in the X-rayed hand were defined as 
having a clinical history consistent with OA. Recruitment ran July 2005-April 2010. Written informed 
consent was obtained from all participants in line with the Declaration of Helsinki (28). Participants 
were excluded if aged <18, pregnant or unable to provide written informed consent for any reason. 
This study was approved by the Bath Multi-centre Research Ethics Committee (REC reference 
05/Q2001/78) and at each NHS Local REC. 
 
2.2. Assessment of radiographs 
All available HBM case and control radiographs, collected across all study centres, were pooled for 
assessment. Files were relabelled and presented in a random order to ensure blinding of the 
assessor. Radiographs were graded by a single observer (AM) following training by an individual with 
previous experience of radiographic OA scoring (SH). X-ray images (all PA) were stored as DICOM 
files and viewed using open source ImageJ software(29); semi-quantitative assessments were 
recorded. 
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We assessed two joints in the hand; the index Distal Interphalangeal Joint (DIPJ) and 1st 
Carpometacarpal Joint (CMCJ), chosen as they are the most commonly affected by OA (in women, 
and our population is predominantly female) (30). Each joint was assigned a semi-quantitative 
grading of individual radiographic features of OA (osteophytes, joint space narrowing and 
subchondral sclerosis) using the established Altman atlas (31), and the presence or absence of mal-
alignment (at the DIPJ), and cysts (at the CMCJ) (table 1). Categorical scores for the individual 
radiographic features were converted to binary variables for analysis. 
 
Image quality was rated by the operator at the time of assessment (good, poor, very poor); very 
poor X-rays, judged in terms of penetration or resolution, were excluded (n=3). At the end of the 
study 40 randomly selected hand X-rays were re-graded by the primary observer (AM) and by a 
secondary observer (SH), to assess intra-rater and inter-rater repeatability respectively. Unweighted 
intra-rater kappa values for the above listed binary variables were all ≥0.60 (considered substantial 
agreement (32)), except CMCJ JSN where binarized as ‘moderate’ (JSN grade≥2) (0.53 [95%CI 0.07, 
1.00]), but when binarized as ‘any JSN’ (JSN grade≥1) agreement was better (0.74 [95%CI 0.53, 
0.95]); DIPJ mal-alignment and CMCJ cysts were not seen amongst this subgroup. The inter-rater 
kappas for all measurements were >0.60, except CMCJ subchondral sclerosis which was rarely seen 
(0.23 [95%CI -0.21, 0.67]). 
 
2.3. Assessment of covariates 
Values for age (at time of X-ray), gender and BMI were obtained.  BMI was calculated as weight 
(kg)/height (metres2). Two non-fasted EDTA samples were collected and plasma separated and 
frozen within 4 hours to -80oC. Bone formation (Procollagen type 1 amino-terminal 
propeptide[P1NP+, total osteocalcin) and resorption (β-C-telopeptides of type I collagen*βCTX+) 
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markers were measured. All had inter- and intra-assay coefficients of variation <6.0% across the 
assay working ranges. Electrochemiluminescence immunoassays (ECLIA) (Roche Diagnostics, Burgess 
Hill, UK) were used to measure plasma concentrations of P1NP, osteocalcin, and βCTX (detection 
limits 4.0, 0.6, 0.01μg/L respectively). 
 
Current and life-time physical activity (PA) was measured by postal questionnaire comprising (i) the 
short last 7 days International PA Questionnaire (IPAQ2002, http://www.ipaq.ki.se/ipaq.htm (33, 
34)) and (ii) historical PA questionnaire (35-37). 87.3% completed PA questionnaires: those who did 
not respond had similar anthropometric characteristics to those who did (supplementary table 1). 
 
2.4. Statistical analysis 
Demographic statistics for the HBM cases and family controls were summarised as mean (SD) for 
continuous variables and counts (percentages) for categorical variables.  Categorical variables were 
initially cross-tabulated and percentages calculated: the chi-squared (χ2) test was used to assess the 
association between binary variables, and the unpaired t-test to compare mean values (or normally 
distributed variables) between cases and controls.  Associations between HBM case status and 
binary radiographic OA outcomes were analysed using logistic regression in a random effects model, 
to allow for the lack of statistical independence due to within-family clustering of environmental 
factors and shared genotypes. Analyses were adjusted for the a priori confounders; age and gender, 
then additionally for (i) BMI and (ii) bone turnover, as potential mediators. The potential influence of 
other potential confounders was assessed. Odds ratios before and after adjustment are presented 
with 95% confidence intervals (95%CI). Analyses were repeated stratified by gender. 
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Pre-planned sensitivity analyses comprised: i) exclusion of poorer quality X-rays, ii) excluding HBM 
cases/ controls with self-reported inflammatory arthritis, iii) excluding HBM cases/ controls with self-
reported steroid use (current or historical), and iv) restricting analyses to HBM cases meeting the 
index case definition at the hip. Data were analysed using Stata release 12 statistical software 
(StataCorp, College Station, TX, USA).  
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3. Results 
3.1. Participant selection and characteristics 
Figure 1 summarises the selection of radiographs for inclusion in our analysis. Of the original study 
population 500 had X-rays performed; those who did not (n=55) were similar in all characteristics 
other than they were more likely to be male, and hence were marginally taller and reported higher 
levels of current physical activity (supplementary table 2). Excluding 3 very poor quality X-rays 
permitted analyses in 314 HBM cases and 183 controls; demographics are detailed in table 2. HBM 
cases were generally older and were more likely to be female, post-menopausal and have used 
estrogen replacement, and had greater BMI compared with controls. As expected, cases had 
substantially higher BMD and BMD Z-scores than controls (supplementary figure 1). 92.8% of the 
study population were right hand dominant. 
 
3.2. HBM and clinical hand OA 
HBM cases more frequently reported a clinical history, and had examination findings, consistent with 
overall hand OA (table 3); however, these findings were fully attenuated by age and gender 
adjustment (table 4). 
 
3.3. HBM and radiographic features of hand OA: unadjusted analyses 
Osteophytes were more commonly seen amongst HBM cases than controls, at both the DIPJ and 
CMCJ, whether graded as any osteophyte (≥grade 1) (DIPJ: 67% vs. 45%; CMCJ 69% vs. 50%; in HBM 
vs. controls respectively), or restricted to moderate and/or more severe osteophytes (≥grade 2) 
(DIPJ: 29% vs. 14%; CMCJ 30% vs. 15%; in HBM vs. controls respectively), p<0.001 for all (table 3). No 
differences between groups were seen in the frequency of either any (≥grade 1) or moderate 
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(≥grade 2) JSN at the DIPJ. At the CMCJ, JSN (≥grade 1) was observed equally frequently amongst 
HBM cases and controls; however, more marked JSN (≥grade 2), whilst being uncommon overall, 
was seen more often amongst HBM cases than family controls (11.8% vs. 3.8% respectively; 
p<0.003). Subchondral sclerosis was uncommon overall, but observed more frequently amongst 
HBM cases than controls, at both joint sites (DIPJ: 8% vs. 3%; CMCJ 12% vs. 7%; in HBM vs. controls 
respectively). Although DIPJ mal-alignment and CMCJ cysts occurred more commonly amongst HBM 
cases, these features were rarely observed. 
 
3.4. HBM and radiographic features of hand OA: analyses adjusted for age and gender 
After adjustment for age and gender clear associations persisted between HBM case status and 
osteophytes, with HBM cases having increased odds of ≥grade 1 osteophytes at the DIPJ (OR 1.82 
[95%CI 1.11, 2.97], p=0.017) and CMCJ (1.89 [1.19, 3.01], p=0.007), and of ≥grade 2 osteophytes at 
the CMCJ (1.85 [1.07, 3.22), p=0.028) (table 4; figure 2). In contrast no association was seen between 
HBM case status and JSN, at either joint site. Furthermore, the associations between HBM case 
status and subchondral sclerosis, DIPJ mal-alignment and CMCJ cysts, were fully attenuated by age 
and gender adjustment. 
 
3.5. HBM and radiographic features of hand OA: analyses with further adjustments 
To determine the extent to which BMI might lie on the causal pathway between HBM and 
osteophytic OA, we further adjusted our age and gender model for BMI (table 4; figure 2). Further 
BMI adjustment marginally attenuated point estimates for osteophyte associations, but otherwise 
similar patterns were still observed. Further adjustment for other potential confounders 
(menopausal status, diabetes mellitus, oestrogen replacement, steroid use) widened confidence 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
Page 13 of 34 
 
intervals but did not influence overall results (supplementary table 3). As physical activity was not 
associated with HBM status this was not considered as a potential confounder (table 1). 
 
To investigate the role differences in bone turnover might play in explaining the association between 
HBM and osteophytic OA, we analysed data from 475 individuals (96% of study population) in whom 
bone turnover marker measures were available, and compared our model adjusted for age, gender, 
BMI, with results further adjusted for CTX, P1NP and osteocalcin (supplementary table 4). 
Adjustment for bone turnover markers did not alter associations or point estimates. 
 
3.6. Gender stratified analyses 
Associations between HBM and radiographic features of OA at the DIPJ were similar across men and 
women (supplementary table 5). Associations between HBM and CMCJ osteophytes (both ≥grade 1 
and ≥grade 2) appeared stronger in women than men; however, no formal evidence of a gender 
interaction was detected (p=0.65 and 0.19 respectively). 
 
3.7. Sensitivity analyses 
25 X-rays (19 HBM cases; 6 controls) were considered to be of poor quality in terms of resolution/ 
penetration. Excluding these from the analyses did not materially influence the observed 
associations (supplementary table 6). 22 participants reported a history of inflammatory arthritis (20 
HBM cases; 2 controls). Exclusion from analyses again did not influence the observed associations 
(supplementary table 7). Exclusion of 113 individuals who reported previous and/or current use of 
steroids, and 12 individuals in whom we lacked data regarding steroid use, widened the confidence 
interval but did not materially influence the point estimate for the association between HBM status 
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and CMCJ osteophytes ≥grade 2, otherwise findings were unchanged (supplementary table 8). 
Amongst HBM cases, 166 individuals had a total Hip Z-score<+3.2. When comparing the remaining 
148 HBM cases and 183 controls point estimates were broadly consistent with the main analysis, 
although confidence intervals widened. There remained a clear association between HBM status and 
CMCJ osteophytes ≥grade 1 (2.03 *1.12, 3.69+, p=0.020) (supplementary table 9).  
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4. Discussion 
We have shown an increased prevalence of radiographic features of OA in non weight-bearing joints 
of the hand, amongst HBM individuals compared with family controls, similar to that we previously 
identified in the weight-bearing joints of the knee and hip (9, 10). As we had hypothesized, 
osteophyte measures were more strongly and consistently associated with HBM, than was JSN, 
consistent with a ‘bone-forming’ phenotype of OA, again in line with our findings at the larger joints 
(9, 10). However, unlike the association we identified between HBM and knee OA, which attenuated 
by approximately 50% after BMI adjustment (10), BMI adjustment did not influence HBM-
osteophyte associations for any radiological grade at either the DIPJ or CMCJ. These findings suggest 
that HBM-osteophyte associations in the hand are independent of weight-bearing and of BMI/ 
metabolic factors. Interestingly, despite lower bone turnover measured amongst HBM cases, further 
adjustment for bone turnover markers, to investigate their potential role on the causal pathway, 
failed to account for the HBM-osteophyte association. 
 
Subchondral sclerosis, a further ‘bone-forming’ feature of OA, whilst uncommon overall, was more 
prevalent amongst HBM cases than family controls in unadjusted analyses. DIPJ mal-alignment and 
CMCJ cysts were also observed more frequently amongst HBM cases than controls; however, 
generally these were rare and fully accounted for by between-group differences in age and gender. 
After taking account of age, gender and BMI, overall odds ratios for osteophytes (≥grade 1) in HBM 
cases vs. controls were similar at the DIPJ (1.72 [1.05, 2.83]), and CMCJ (1.76 [1.10, 2.83]) as 
previously reported at the hip (2.12 [1.61,2.79])(9) and the knee (1.62 [1.21,2.15])(10), suggesting 
that the increased risk of osteophytes conferred as a direct result of HBM (independent of BMI) is 
similar across all joint sites. 
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Our findings are consistent with epidemiological evidence from the general population, that 
increased BMD is a risk factor for hand OA (1, 38, 39). Whilst a number of studies have assessed the 
relationship between BMD and radiographic OA of knees and hips, many fewer have focussed on the 
hand. Of those that have, most use the global score of Kellgren and Lawrence (20), rather than 
feature-specific grades as we have done (40). Although, one study from 1995 examined radiographic 
hand OA in 300 healthy older women, deriving global osteophyte and JSN scores (graded 0-30) using 
10 joints. Interestingly the osteophyte, but not JSN score was positively correlated with BMD, 
apparently independent of BMI although data were not shown (38); authors speculated bone 
density and osteophytosis may therefore have common genetic determinants. More recently, a 
larger Korean study identified a positive relationship between BMD and both hand osteophytes and 
sclerosis, with an inverse relationship seen between BMD and JSN in the hand (41), highlighting the 
importance of individual grading of OA sub-phenotypes. 
 
Extreme HBM is likely to be genetically determined with onset of elevated bone mass developing 
relatively early in life, likely before the onset of OA; the genetic basis of increased BMD in our HBM 
population is currently being investigated (42). Potentially, the genetic influences governing BMD 
might also affect cartilage and OA risk. Wnt signalling is an important regulator of osteoblastic bone 
formation and mutations activating this pathway produce a HBM phenotype (19). Polymorphisms in 
genes thought to regulate the Wnt pathway, plus reduced levels of the Wnt pathway inhibitor DKK1, 
have both been associated with knee OA (43-45). Furthermore, osteophytes form by endochondral 
ossification, reactivation of which is thought to play an important role in OA development in adult 
joints (46-48). Polymorphisms associated with OA susceptibility lie close to genes involved in the 
regulation of endochondral ossification (49). Interestingly, genetic variation at loci associated with 
both endochondral ossification and Wnt signalling (50), is greater amongst our HBM population (14).  
Therefore, despite lack of temporal data, we consider the relationships we report here, to most 
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likely reflect either a causal pathway between higher BMD and increased risk of ‘bone-forming’ 
features of OA, or genetic pleiotropy. 
 
It remains theoretically possible that OA features within the DXA field (e.g. lumbar osteophytosis) 
could lead to artefactual elevation of measured BMD, with the potential to induce a spurious HBM-
OA association if spine and hand OA are correlated as part of a “generalised OA” phenotype.  As 
discussed, every effort was made within the study design to avoid such misclassification of HBM 
status; DXA scans were visually inspected for artefactual causes of raised BMD including significant 
OA, and the L1 vertebra was selected for case definition as L1 Z-scores were not associated with 
features of OA visible on lumbar DXA (12, 21). In fact, this approach may have led to some 
individuals with both HBM and OA being excluded, which if anything would bias our results towards 
the null. Reassuringly, hip OA has been shown to only minimally influence measured hip BMD (51), 
and sensitivity analyses limited to HBM cases with hip predominant HBM generated point estimates 
similar to overall results. 
 
4.1. Limitations 
Since controls were recruited from within families, they are likely to have greater similarity to HBM 
cases than unrelated general population controls; hence clustered analyses were performed to 
account for the lack of statistical independence due to within-family clustering of environmental 
factors and shared genotypes. Despite this, our reported differences may still underestimate the 
true magnitude of the HBM phenotype. Considering referral indications for clinical DXA services, our 
study design most likely accounts for the observed differences between cases and controls in 
gender, age, post-menopausal status, estrogen replacement and steroid use. However, older age, 
greater body weight and female gender are all established risk factors for OA (16, 52), and 
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symptomatic hand OA is particularly seen in post-menopausal women (53). As the HBM cases were 
older, more likely to be female and post-menopausal, and have a higher BMI than family controls, 
our results may be explained by residual confounding as regression models may not fully adjust for 
these marked differences. 
 
Some radiographs for both cases and controls were unavailable; less mobile participants with OA 
may have been less likely to have attended for X-rays, potentially leading to underestimation of the 
true OA prevalence within our study population. We lacked data regarding any historic hand joint 
injuries as well as precise joint specific examination findings, hence our reporting of global hand OA, 
which meant the potential differences between finger and thumb examination findings could not be 
determined. Between-centre variations in radiographic protocols may have introduced 
measurement error; however, in affecting both cases and controls, the expected effect would be to 
bias our results towards the null. We lack temporal data, so the direction of causality cannot be 
formally assessed; nevertheless, we assume the onset of genetically determined HBM would predate 
the onset of OA (a disease of later life) in this population. However, it is theoretically possible that 
OA features within the DXA field (e.g. lumbar osteophytosis) could lead to artefactual elevation of 
measured BMD, with the potential to induce a spurious association between HBM and OA if spine 
and hand OA are correlated as part of a “generalised OA” phenotype.  As discussed, every effort was 
made to avoid such misclassification of HBM status through both inspection of DXA images and our 
case definition; also the fact that the association between HBM and hand OA remained robust when 
restricted to those HBM cases with high hip BMD is reassuring (supplementary table 9), as hip OA is 
thought to have only a minimal influence on measured hip BMD (51). A single blinded observer 
graded all radiographs, which may have led to either over or underestimation of OA prevalence 
rather than affecting between-group differences; this strategy was chosen as intra-rater 
repeatability of semi-quantitative OA scoring is substantially superior to that between observers 
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(54). Ideally all radiographs would have been dual graded, enabling robust calculation of agreement 
for rarer characteristics. 
 
5. Conclusion 
In conclusion, our findings support a positive association between HBM and osteophytosis in non-
weight-bearing joints of the hand, which is independent of BMI. HBM-associated OA is characterised 
by osteophytes, consistent with a ‘bone forming’ phenotype, rather than JSN reflecting cartilage 
loss, and is similar to the phenotype we have previously reported in weight-bearing joints of the 
knee and hip (9, 10). However, this ‘bone forming’ hand phenotype is not explained by the lower 
bone turnover seen in adult HBM cases. It is possible that the same systemic factors, for example 
genetic architecture, which govern HBM may also increase the risk of osteophytosis.  
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Figure legends 
Figure 1: Flow diagram summarising selection of radiographs for inclusion in the study. Selection 
of High Bone Mass (HBM) case and family control X-rays (process of recruitment to study 
described previously).  1Reason recorded for missing X-rays in HBM cases: unable to travel (n=7), 
no X-rays at study centre (n=10), unable to attend / wait / comply (n=3), patient declined (n=6), 
reside abroad (n=2), reason unknown (n=11).  2Reason recorded for missing X-ray in family 
controls: unable to travel (n=1), did not continue in study (n=1), no X-rays at study centre (n=4), 
unable to attend / wait / comply (n=3), patient declined (n=2), reason unknown (n=5). 
Figure 2: Odds ratios for osteophytes (≥grade 1) at the Index Distal Interphalangeal Joint (DIPJ) (A) 
and 1st Carpometacarpal Joint (CMCJ) (B); stratified by gender and combined. Square symbols 
represent point estimates aged for age and gender when combined. Circular symbols represent 
point estimates aged for age and BMI, as well as gender when combined. No evidence for a gender 
interaction was identified. (Males n=179, Females n=318, Combined n=497). OR and 95% CI shown. 
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Table 1.  Semi-quantitative scoring of radiographic features of CMCJ and DIPJ osteoarthritis.  
Grading of individual radiographic features was performed using the Altman atlas (31).  OP = 
osteophyte. 
 
OA feature 
Categorical 
grading 
Binary variable(s) 
Osteophytes 0-3 Any osteophyte (any OP grade ≥1), moderate 
osteophyte (any OP grade ≥2) 
Joint space narrowing (JSN) 0-3 Any JSN (JSN grade ≥1), moderate JSN (JSN grade ≥2) 
Subchondral sclerosis 0-1 Subchondral sclerosis (grade ≥1) 
Mal-alignment (DIPJ only) 0-1 Mal-alignment (grade ≥1) 
Cysts (CMCJ only) 0-1 Cysts (grade ≥1) 
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Table 2: Demographics of study population 
HBM: High Bone Mass. SD: Standard Deviation. BMI: Body Mass Index. PA: Physical activity. IPAQ: 
International Physical Activity Questionnaire.  a n=475, b post-menopausal estrogen replacement 
therapy. c previous or current, includes eye drops, intra-articular steroid injections and oral steroids for 
e.g. asthma, PMR, ulcerative colitis. d from any mechanism. e constructed using best available evidence, 
grading PA between 0 (no PA) & 24 (very high PA) (35-37). 
 
 HBM cases (n=314) Controls (n=183) p value 
 Mean (SD) Mean (SD)  
Age  (years) 61.1 (14.1) 54.3 (16.3) <0.001 
Height  (cm) 167.1 (8.7) 171.1 (10.2) <0.001 
Weight  (kg) 85.6 (16.9) 83.2 (17.4) 0.109 
BMI (kg/m2) 30.8 (5.8) 28.5 (5.0) <0.001 
L1 Z-score 3.96 (1.5) 0.56 (1.2) <0.001 
Total Hip Z-score 3.04 (1.2) 0.63 (0.89) <0.001 
P1NP (μg/L) a 36.1 (19.9) 40.7 (22.3) 0.022 
Osteocalcin (total) (μg/L) a 15.8 (7.9) 18.0 (8.0) 0.003 
CTX (μg/L) a 0.20 (0.13) 0.24 (0.17) 0.005 
 n (%) n (%)  
Female 234 (74.5) 84 (45.9) <0.001 
    Postmenopausal 187 (80.6) 45 (55.6) <0.001 
    Estrogen replacement  use (ever)b 109 (51.4) 15 (20.8) <0.001 
Diabetes Mellitus 37 (11.8) 12 (6.6) 0.064 
Self-reported osteoarthritis 72 (22.9) 28 (15.3) 0.040 
Self-reported inflammatory arthritis 20 (6.4) 2 (1.1) 0.013 
Steroid use (ever)c 82 (26.5) 31 (17.7) 0.030 
Previous fractured 120 (38.2) 85 (46.7) 0.065 
Current PA (IPAQ) (n=434) 
Low 45 (14.3) 19 (10.4)  
Moderate 104 (33.1) 53 (29.0) 0.188 
High 132 (42.0) 81 (44.3)  
Historical PA scoree (n=431) 
Very low (0-4) 33 (10.5) 17 (9.3) 
0.288 
Low (5-7) 56 (17.8) 40 (21.9) 
Moderate (8-10) 60 (19.1) 36 (19.7) 
High(11-14) 66 (21.0) 28 (15.3) 
Very high(15-24) 63 (20.1) 32 (17.5) 
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Table 3: Unadjusted osteoarthritis variables at the Index Distal Interphalangeal Joint (DIPJ) and 1st 
Carpometacarpal Joint (CMCJ) 
JSN: Joint Space Narrowing; OR: Odds Ratio 
 
 
HBM cases 
(n 314) 
Controls 
(n 183) 
OR (95% CI) p value 
 n (%) n (%)   
Symptomatic hand OAa      
Clinical history of hand OA 91 (29.0) 31 (16.9) 2.08 (1.29, 3.36) 0.003 
Clinical exam suggesting hand OA 89 (28.3) 33 (18.0) 1.89 (1.17, 3.05) 0.009 
DIPJ radiographic grading     
Any osteophyte (≥grade 1) 210 (66.9) 83 (45.4) 2.51 (1.69, 3.73) <0.001 
Moderate osteophytes (≥grade 2) 92 (29.3) 26 (14.2) 2.61 (1.58, 4.33) <0.001 
Any JSN (≥grade 1) 122 (38.9) 61 (33.3) 1.29 (0.87, 1.91) 0.213 
Moderate JSN (≥grade 2) 22 (7.0) 11 (6.0) 1.20 (0.55, 2.58) 0.649 
Subchondral sclerosis 25 (8.0) 6 (3.3) 2.58 (1.02, 6.55) 0.046 
Mal-alignment 17 (5.4) 1 (0.5) 11.0 (1.42, 84.9) 0.022 
CMCJ radiographic grading     
Any osteophyte (≥grade 1) 218 (69.4) 92 (50.3) 2.33 (1.56, 3.49) <0.001 
Moderate osteophytes (≥grade 2) 94 (29.9) 27 (14.8) 2.55 (1.56, 4.18) <0.001 
Any JSN (≥grade 1) 134 (42.7) 73 (39.9) 1.13 (0.77, 1.67) 0.521 
Moderate JSN (≥grade 2) 37 (11.8) 7 (3.8) 3.65 (1.53, 8.71) 0.003 
Subchondral sclerosis 38 (12.2) 12 (6.6) 2.05 (1.01, 4.13) 0.045 
Cysts 11 (3.5) 1 (0.5) 7.25 (0.90, 58.6) 0.063 
a Clinical history and examination findings relate to the same side as was X-rayed for each individual 
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Table 4: Osteoarthritis variables at the Index Distal Interphalangeal Joint (DIPJ) and 1st 
Carpometacarpal Joint (CMCJ) adjusted for age and sex, with additional adjustment for BMI 
JSN: Joint Space Narrowing; OR: Odds Ratio. Based on 314 HBM cases and 183 controls. 
 
 OR (95% CI) p value OR (95% CI) p value 
 
Adjusted for age 
& Sex 
 
Adjusted for age & 
Sex & BMI 
 
Symptomatic hand OAa      
Clinical history of hand OA 1.20 (0.72, 1.99) 0.493 1.15 (0.68, 1.94) 0.595 
Clinical exam suggesting hand OA 1.03 (0.61, 1.73) 0.908 1.05 (0.62, 1.78) 0.849 
DIPJ radiographic grading     
Any osteophyte (≥grade 1) 1.82 (1.11, 2.97) 0.017 1.72 (1.05, 2.83) 0.032 
Moderate osteophytes (≥grade 2) 1.51 (0.86, 2.65) 0.155 1.47 (0.83, 2.61) 0.183 
Any JSN (≥grade 1) 0.85 (0.54, 1.34) 0.492 0.76 (0.48, 1.21) 0.242 
Moderate JSN (≥grade 2) 0.65 (0.29, 1.46) 0.297 0.65 (0.28, 1.47) 0.301 
Subchondral sclerosis 1.22 (0.46, 3.23) 0.687 1.40 (0.52, 3.72) 0.505 
Mal-alignment 5.33 (0.67, 42.7) 0.115 4.77 (0.59, 38.5) 0.142 
CMCJ radiographic grading         
Any osteophyte (≥grade 1) 1.89 (1.19, 3.01) 0.007 1.76 (1.10, 2.83) 0.019 
Moderate osteophytes (≥grade 2) 1.85 (1.07, 3.22) 0.028 1.75 (1.00, 3.06) 0.049 
Any JSN (≥grade 1) 0.85 (0.55, 1.31) 0.449 0.77 (0.50, 1.21) 0.256 
Moderate JSN (≥grade 2) 1.87 (0.75, 4.66) 0.181 1.68 (0.67, 4.22) 0.272 
Subchondral sclerosis 0.97 (0.46, 2.05) 0.928 1.02 (0.48, 2.18) 0.957 
Cysts 3.73 (0.44, 31.5) 0.226 3.71 (0.43, 32.0) 0.233 
a Clinical history and examination findings relate to the same side as was X-rayed for each individual 
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Figure 1 
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Figure 2 
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Highlights 
 High Bone Mass (HBM) is characterised by osteophytosis in non weight-bearing joints of the 
hand 
 Hand osteophytosis is not explained by the higher BMI or by the lower bone turnover seen 
in HBM 
 HBM-associated OA, characterised by osteophytes, is consistent with a ‘bone forming’ 
phenotype 
 A similar ‘bone forming’ phenotype has been observed in weight-bearing joints of the knee 
and hip in HBM 
 Systemic factors, e.g. genetic architecture, which govern HBM may also increase the risk of 
osteophytosis 
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